Matches in Wikidata for { <http://www.wikidata.org/entity/Q64183405> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q64183405 description "clinical trial" @default.
- Q64183405 description "ensayu clínicu" @default.
- Q64183405 description "klinisch onderzoek" @default.
- Q64183405 description "клінічне випробування" @default.
- Q64183405 description "կլինիկական փորձարկում" @default.
- Q64183405 name "Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications" @default.
- Q64183405 type Item @default.
- Q64183405 label "Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications" @default.
- Q64183405 prefLabel "Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications" @default.
- Q64183405 P1132 Q64183405-A5D9955C-7321-467B-AD6E-0A62B35FBAB8 @default.
- Q64183405 P1476 Q64183405-D96D0AD2-5527-4FDA-B46E-67D702F103E4 @default.
- Q64183405 P1813 Q64183405-0806BBE6-9A77-4321-9E79-1C02C4AEF3B2 @default.
- Q64183405 P2899 Q64183405-BC87D517-CAA9-4202-AFAB-C8D7247ADA73 @default.
- Q64183405 P3098 Q64183405-0F50241B-D17B-46F1-BB18-EEAA4FB4407A @default.
- Q64183405 P31 Q64183405-A08DC495-4A81-4C16-977D-04E79CF96210 @default.
- Q64183405 P4844 Q64183405-1AA6C63F-FDCE-4950-9FAC-ADD81D55274F @default.
- Q64183405 P4844 Q64183405-4A0A6A0C-05AB-4930-AB3F-C789E79044DF @default.
- Q64183405 P580 Q64183405-ECACFB17-B3C7-477F-97DF-9C21B4FC5474 @default.
- Q64183405 P582 Q64183405-9B4255FC-88B5-49D9-8625-3DBE682C66CE @default.
- Q64183405 P6099 Q64183405-04C69D16-3B3E-4863-A4BD-2A2681DE690D @default.
- Q64183405 P8363 Q64183405-DAA5F855-37C3-4C70-B89A-240D1B5C9151 @default.
- Q64183405 P1132 "+2184" @default.
- Q64183405 P1476 "A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Patients With Influenza at High Risk of Influenza Complications" @default.
- Q64183405 P1813 "CAPSTONE 2" @default.
- Q64183405 P2899 "+12" @default.
- Q64183405 P3098 "NCT02949011" @default.
- Q64183405 P31 Q30612 @default.
- Q64183405 P4844 Q211509 @default.
- Q64183405 P4844 Q57742876 @default.
- Q64183405 P580 "2017-01-11T00:00:00Z" @default.
- Q64183405 P582 "2018-04-12T00:00:00Z" @default.
- Q64183405 P6099 Q42824827 @default.
- Q64183405 P8363 Q78089383 @default.